Regenerative medicine - Science and Technology Committee Contents


Evidence is published online at and available for inspection at the Parliamentary Archives (020 7219 5314)

Evidence received by the Committee is listed below in chronological order of oral evidence session and in alphabetical order. Those witnesses marked with * gave both oral evidence and written evidence. Those marked with ** gave oral evidence and did not submit any written evidence. All other witnesses submitted written evidence only.

Oral evidence in chronological order
**QQ 1-20 Professor Charles ffrench-Constant, Professor of Multiple Sclerosis Research; Director; Theme leader Neural Differentiation and Tissue Repair, Centre for Regenerative Medicine, University of Edinburgh
** Dr Ludovic Vallier, Stem Cell Institute, University of Cambridge
* Professor Steven Sacks, Professor of Nephrology; Head of the Division of Transplantation Immunology and Mucosal Biology and Director of the Medical Research Council (MRC) Centre for Transplantation, King's College London
* Professor Michael Linden, Professor of Virology, and Director of the University College London (UCL) Gene Therapy Consortium, King's College London
**QQ 21-41 Professor Peng Tee Khaw, Moorfield's Eye Hospital, University College London (UCL)
* Professor Roger Barker, University of Cambridge
** Professor Michael Schneider, Imperial College London
*QQ 42-63 Professor Dame Sally Davies, Chief Medical Officer and Chief Scientific Adviser, Department of Health (DH)
* Medical Research Council (MRC)
* Wellcome Trust
* British Heart Foundation (BHF)
*QQ 64-80 Professor Robin Ali, Professor of Human Molecular Genetics, University College London (UCL)
* Professor Graham Lord, Professor of Medicine and Head of Department of Experimental Immunobiology, and Director of NIHR Biomedical Research Centre, Guy's and St. Thomas' NHS, King's College London
** Sir John Tooke, Vice-Provost (Health), Head of the Medical School and Academic Director of the Academic Health Science Centre, University College London (UCL)
*QQ 81-127 Dr Paul Kemp, Intercytex Ltd
* Professor Anthony Hollander, Head of the School of Cellular and Molecular Medicine at the University of Bristol, and Chief Scientific Officer, Azellon
** Smith & Nephew
*QQ 128-169 Dr  Ruth McKernon, Pfizer
* Professor Chris Mason, Professor of Regenerative Medicine Bioprocessing, University College London (UCL)
* Michael Hunt, ReNeuron
**QQ 170-195 Dr Navid Malik, Head of Life Sciences Research, Cenkos Security
** Dr Nigel Pitchford, Managing Director of Healthcare, Imperial Innovations
** Dr Steven Dyson, Partner, Healthcare team, Apax Partners
**QQ 196-213 Intellectual Property Office (IPO)
* Lawford Davies Denoon
** Professor Peter Andrews, Arthur Jackson Professor of Biomedical Science and Co-Director of the Centre for Stem Cell Biology, University of Sheffield
*QQ 214-243 National Institute for Health and Clinical Excellence (NICE)[332]
* TiGenix NV
* Bupa Health and Wellbeing UK
**QQ 244-266 Aidan Courtney, Roslin Cells Limited
* Scottish National Blood Transfusion Service (SNBTS)
* UK Stem Cell Bank
*QQ 267-282 Professor David Williams, Engineering and Physical Science Research Council (EPSRC) Centre for Innovative Manufacturing in Regenerative Medicine
* Keith Thompson, Cell Therapy Catapult Centre
** TAP Biosystems
*QQ 283-294 Keith Thompson, Cell Therapy Catapult Centre
* Technology Strategy Board (TSB)
*QQ 295-316 Medical and Healthcare products Regulation Agency (MHRA)
** European Medicine Agency
* Health Research Authority
*QQ 317-329 Human Fertilisation and Embryology Authority (HFEA)
* Human Tissue Authority (HTA)
**QQ 330-342 Genetic Alliance UK
* Consulting on Advanced Biologicals (CAB) Ltd
* LGC Limited
*QQ 343-356 Professor Sir Bruce Keogh, NHS Medical Director
** Professor Richard Lilford, University of Birmingham
* NHS England
*QQ 357-366 Rt Hon Earl Howe, Parliamentary Under-Secretary of State and Government Spokesperson, Department of Health (DH)
* Rt Hon David Willetts MP, Minister of State for Science and Universities, Department of Business, Innovation and Skills (BIS)

Alphabetical list of all witnesses

  Alliance for Advanced Therapies (AAT)

  Alliance for Regenerative Medicine (ARM)

**  Professor Peter Andrews, University of Sheffield

  Anscombe Bioethics Centre

  Anthony Nolan

  Applied regenerative science group, University College London (UCL)

  Arthritis Research UK

  Association of British Neurologists (ABN)

  Association of British Pharmaceutical Industry (ABPI)

  Association of Medical Research Charities (AMRC)

*  Azellon Cell Therapeutics Ltd

  BioIndustry Association (BIA)

*  British Heart Foundation (BHF)

  British Society for Blood and Marrow Transplantation (BSBMT)

  British Society for Haematology (BSH)

  British Society for Oral & Dental Research (BSODR)

  Professor Robert Brown, University College London (UCL)

*  Bupa

  California Institute for Regenerative Medicine (CIRM)

  Cambridge National Institute for Health Research

CASMI (Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation)

*  Cell Therapy Catapult Limited

*  Consulting on Advanced Biologicals (CAB) Ltd

  Trevor Cook, partner at Bird & Bird

  Professor Charles Craddock, University Hospital Birmingham

  Cytori Therapeutics

Professor Dame Kay Davies, Dr Lee's Professor of Anatomy, University of Oxford

  Professor Stephen Davies, University of Oxford

*  Department of Business Innovation and Skills (BIS)

*  Department of Health (DH)

  Professor Stephen Dunnett, Cardiff University

**  Dr Steven Dyson, Apax Partners

  Edinburgh BioQuarter

  Engineering and Physical Sciences Research Council (EPSRC)

*  Engineering and Physical Science Research Council (EPSRC) Centre for Innovative Manufacturing in Regenerative Medicine

**  European Medicine Agency

**  Professor Charles ffrench-Constant, University of Edinburgh

  GE Healthcare

*  Genethon (France) Gene Therapy GMP Facility

**  Genetic Alliance UK

Iva Hauptmannova, Royal National Orthopaedic Hospital (RNOH) NHS Trust

  Professor John Haycock, University of Sheffield

  Health Protection Agency (HPA)

*  Health Research Authority (HRA)

  HealthTech and Medicines Knowledge Transfer Network (Health KTN)

*  Headquarters Surgeon General, Ministry of Defence (MOD)

  Julian Hitchcock (Counsel, Lawford Davies Denoon)

*  Professor Anthony Hollander, University of Bristol and Azellon

*  Human Fertilisation and Embryology Authority (HFEA)

*  Human Tissue Authority (HTA)

**  Intellectual Property Office (IPO)

  JACIE (Joint Accreditation Committee-ISCT & EBMT)

  Professor William James, University of Oxford

*  Paul Kemp PhD

**  Professor Peng Tee Khaw, University College London (UCL)

*  King's College London (KCL)

  King's Health Partners (KHP)

  Korea Health Industry Development Industry (KHIDI)

*  Lawford Davies Denoon (LDD)

  Leukaemia & Lymphoma Research (LLR)

*  LGC Limited

  Life Science Investment Organisation of UK Trade and Investment

**  Professor Richard Lilford, University of Birmingham

*  Professor Michael Linden, King's College London (KCL)

  London Regenerative Medicine Network (LRMN)

  Professor Sheila MacNeil, University of Sheffield

**  Dr Navid Malik, Cenkos Security

*  Professor Chris Mason, University College London (UCL)

*  Medical Research Council (MRC)

  Medical Technologies Innovation Knowledge Centre, University of Leeds

*  Medicines and Healthcare products Regulatory Agency (MHRA)

  Miltenyi Biotec Ltd

*  National Institute for Health and Clinical Excellence (NICE)[333]

  National Institute for Social Care and Health Research (NISCHR)

*  NHS Blood and Transplant (NHSBT)

*  NHS England

*  NHS Health Research Authority

  Nutech Mediworld

  Oxford Stem Cell Institute (OSCI)

*  Parkinson's UK

*  Pfizer

**  Dr Nigel Pitchford, Imperial Innovations

  Dr Mahendra Rao, National Institutes of Health

*  Regener8

*  ReNeuron

*  Research Councils UK (RCUK)

  Professor Stephen Rimmer, University of Sheffield

**  Roslin Cells Limited

  Professor Anne Rosser, Cardiff University

  Royal College of Pathologists (RCPath)

  Royal Society of Chemistry (RSC)

  Dr Angela Russell, University of Oxford

*  Professor Steven Sacks, King's College London (KCL)

  Chiaki Sato, University of Tokyo

**  Professor Michael Schneider, Imperial College London

  Scottish Enterprise

Scottish Government—Alex Neil MSP Cabinet Secretary for Health and Wellbeing

*  Scottish National Blood Transfusion Service (SNBTS)


**  Smith & Nephew

  Dr John Snowden, Sheffield Teaching Hospitals

**  TAP Biosystems

*  Technology Strategy Board (TSB)

*  TiGenix NV

  Tissue Regenix Group plc

**  Sir John Tooke, University College London (UCL)

  UCB Pharma Ltd

  UCL Institutes of Child Health and Women's Health

  UK Regenerative Medicine Community

*  UK Stem Cell Bank

  UK Stem Cell Foundation

  University of Manchester

**  Dr Ludovic Vallier, University of Cambridge

Professor Andrew Webster, Science and Technology Studies Unit (SATSU) University of York

*  Wellcome Trust

  Wellcome Trust Sanger Institute

  Welsh Government

  Dr Robert Westwood, ex Pharma & Biotech Industry

  Dr Graham Wynne, University of Oxford

332   NICE's name was changed from the National Institute for Health and Clinical Excellence to the National Institute for Health and Care Excellence on 1 April 2013. Its evidence was submitted in its former name and so is recorded as such. Recommendations we make to it use its current name. Back

333   NICE's name was changed from the National Institute for Health and Clinical Excellence to the National Institute for Health and Care Excellence on 1 April 2013. Its evidence was submitted in its former name and so is recorded as such. Recommendations we make to it use its current name. Back

previous page contents next page

© Parliamentary copyright 2013